ALK and adenocarcinoma: This ALK gene rearrangement has been identified in 3-13 % of NSCLC patients and is significantly associated with young, female, non-smoking patients and with adenocarcinoma subtype with solid signet ring cell features and advanced stage of disease [11–40].